7TYN image
Entry Detail
PDB ID:
7TYN
EMDB ID:
Title:
Calcitonin Receptor in complex with Gs and salmon calcitonin peptide
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2022-02-13
Release Date:
2022-03-30
Method Details:
Experimental Method:
Resolution:
2.60 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Guanine nucleotide-binding protein G(s) subunit alpha isoforms short
Chain IDs:C (auth: A)
Chain Length:394
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1
Chain IDs:D (auth: B)
Chain Length:350
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2
Chain IDs:E (auth: G)
Chain Length:71
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Nanobody 35
Chain IDs:F (auth: N)
Chain Length:138
Number of Molecules:1
Biological Source:Lama glama
Polymer Type:polypeptide(L)
Description:Calcitonin-1
Chain IDs:A (auth: P)
Chain Length:33
Number of Molecules:1
Biological Source:Salmo salar
Polymer Type:polypeptide(L)
Description:Calcitonin receptor
Chain IDs:B (auth: R)
Chain Length:501
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
A structural basis for amylin receptor phenotype.
Science 375 eabm9609 eabm9609 (2022)
PMID: 35324283 DOI: 10.1126/science.abm9609

Abstact

Amylin receptors (AMYRs) are heterodimers of the calcitonin (CT) receptor (CTR) and one of three receptor activity-modifying proteins (RAMPs), AMY1R, AMY2R, and AMY3R. Selective AMYR agonists and dual AMYR/CTR agonists are being developed as obesity treatments; however, the molecular basis for peptide binding and selectivity is unknown. We determined the structure and dynamics of active AMYRs with amylin, AMY1R with salmon CT (sCT), AMY2R with sCT or human CT (hCT), and CTR with amylin, sCT, or hCT. The conformation of amylin-bound complexes was similar for all AMYRs, constrained by the RAMP, and an ordered midpeptide motif that we call the bypass motif. The CT-bound AMYR complexes were distinct, overlapping the CT-bound CTR complexes. Our findings indicate that activation of AMYRs by CT-based peptides is distinct from their activation by amylin-based peptides. This has important implications for the development of AMYR therapeutics.

Legend

Protein

Chemical

Disease

Primary Citation of related structures